Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Roadzen Inc. entered into amendments to restricted stock unit (RSU) awards for its CEO, CFO, COO, and other employees to extend their vesting dates by one year. Specifically, 5,616,550 RSUs for CEO Rohan Malhotra and 1,250,007 RSUs for COO Ankur Kamboj will now vest in September 2027, while 115,000 RSUs for CFO Jean-Noël Gallardo will vest in November 2027.
Bryn Inc. announced a 1-for-100,000 reverse stock split of its common stock effective September 23, 2026. In conjunction with the split, the company will change its name to MEDO Technologies, Inc. and expects to trade under the new symbol 'MEDO' on the OTCID Market starting September 24, 2026.
Allarity Therapeutics has been granted Japanese Patent No. 7917283 by the Japan Patent Office, covering its proprietary stenoparib-specific Drug Response Predictor (DRP) companion diagnostic. The patent provides intellectual property protection in Japan through 2039 for methods of predicting clinical benefit and selecting patients for stenoparib treatment. This follows similar patent protections already secured in the United States, Europe, and Australia.
SunCoke Energy, Inc. appointed Wendell L. Carter, a veteran steel industry executive and former Executive Vice President at Cleveland-Cliffs, to its Board of Directors. Mr. Carter will serve on the Compensation and Governance Committees and will participate in the company's standard non-employee director compensation program. His appointment is intended to provide the board with significant expertise in steelmaking technology, engineering, and facility optimization.
Barnwell Industries Divestiture to David Johnston for $1.77M
Barnwell Industries completed the sale of its remaining Hawaii development interests and related project rights to David Johnston for a gross purchase price of $1.77 million. The transaction, which resulted in total cash receipts of approximately $1.7 million to the company, marks Barnwell's complete exit from its legacy Hawaii real estate portfolio. The company intends to refocus its capital on strategic investments and acquisitions within its core energy and related asset operations.
Xenetic Biosciences entered into a definitive share exchange agreement to acquire Santersus AG in an all-stock transaction. Upon closing, Santersus shareholders are expected to own approximately 85% of the combined company, which will focus on NET-targeting therapeutics and trade under the new ticker symbol SNTS.
Clear Secure, Inc. announced that President and Board member Michael Barkin will transition to an advisory role on October 15, 2026, and resign from the Board. Additionally, Kyle McLaughlin, EVP of Aviation, notified the company of his resignation effective October 2, 2026, to pursue a new opportunity.
Profusa Debt Financing Update with Ascent Partners Fund LLC
Profusa, Inc. issued a senior secured convertible promissory note to Ascent Partners Fund LLC with a principal amount of $384,615.38 for a purchase price of $350,000. The note bears 7% interest, matures in September 2027, and is secured by substantially all of the company's assets. It is convertible into common stock at a price of $4.28 per share, subject to a floor price of $1.07.
Karman Holdings Inc. (KRMN) released an investor presentation titled 'Karman Space & Defense Investor Update' on September 16, 2026. The presentation, led by CEO Jon Rambeau, provides a strategic update on the company's operations and market position within the space and defense sectors.
On September 14, 2026, Binbin Wu, Jiayang Ma, and Bo Shan resigned from the Board of Directors of Longduoduo Company Limited. The company stated that the resignations were not due to any disagreements regarding operations, policies, or procedures.
Beneficient entered into subscription agreements with three of its executives and directors for the private placement of 33,019 shares of Class A common stock. The shares were sold at a price of $1.06 per share to CEO James G. Silk, Chief Fiduciary Officer Derek L. Fletcher, and Director Peter T. Cangany, Jr.
Counterparty
Peter T. Cangany, Jr., Derek L. Fletcher, and James G. Silk
Oscar Health is hosting its 2026 Investor Day to discuss its long-term strategy and financial targets. During the event, the company raised its full-year 2026 guidance for Earnings from Operations to a range of $600 million to $800 million and improved its Medical Loss Ratio outlook.
Huntington Bancshares filed a formal presentation deck for its participation in the 2026 Barclays Global Financial Services Conference. Chairman and CEO Steve Steinour and CFO Zach Wasserman are scheduled to present the slides to analysts and investors on September 16, 2026.
Artificial Intelligence Technology Solutions Wins Contract from major national automotive retailer
Artificial Intelligence Technology Solutions (AITX) received orders for nine standalone ROSA security units licensed with SARA (Speaking Autonomous Responsive Agent). The orders include a first-time six-unit deployment for a major national automotive retailer and a three-unit expansion for an existing construction-sector customer.
HIVE Digital Technologies announced that its average daily revenue from Bitcoin mining and GPU services has surpassed $1 million as of August 21, 2026. Additionally, the company's subsidiary BUZZ High Performance Computing appointed AI and HPC veteran Mark Volk as Senior Vice President, Revenue to lead its global go-to-market strategy.
FG Nexus Inc. reported progress on its common and preferred stock repurchase programs, having repurchased approximately 4.0 million common shares for $48.0 million and 275,000 preferred shares for $6.9 million. The common stock repurchases represent approximately 46% of the shares outstanding prior to the program's implementation. Both programs remain authorized and open-ended as part of the company's capital-allocation strategy.
NRx Pharmaceuticals received notification from the FDA reclassifying a previously 'Major' amendment to its Abbreviated New Drug Application (ANDA) for preservative-free ketamine as a 'Minor' amendment. This reclassification accelerates the regulatory timeline, resulting in a revised GDUFA goal date of November 10, 2026.
News Corp provided a daily update on its $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The filing includes notifications of recent buy-back transactions for its Nasdaq-listed Class A common stock. The program allows for the repurchase of both Class A and Class B common stock from time to time based on market conditions.
Lionsgate Studios Corp. held its Annual General and Special Meeting of Shareholders on September 15, 2026. Shareholders elected all 11 director nominees, reappointed Ernst & Young LLP as the independent auditor, and approved executive compensation on an advisory basis.
Expand Energy $500M Debt Financing with Citigroup Global Markets Inc. and J.P. Morgan Securities LLC
Expand Energy Corporation entered into an underwriting agreement for the public offering of $500 million in 5.650% Senior Notes due 2031. The notes were priced at 99.889% of their face value, and the company intends to use the net proceeds for general corporate purposes.
Value
$500M
Counterparty
Citigroup Global Markets Inc. and J.P. Morgan Securities LLC
Brookfield Asset Management, through its flagship private equity strategy, has entered into a definitive agreement to acquire 100% of Reliance Worldwide Corporation (ASX: RWC) for an enterprise value of approximately $2.8 billion. The all-cash proposal of $3.38 per share has been unanimously recommended by the Reliance Board and is expected to close in Q1 2027. The acquisition aims to leverage Brookfield's industrial expertise to support Reliance's growth as a global leader in plumbing and heating solutions.
AtlasClear Holdings $500K Debt Financing with Sixth Borough Capital Fund, LP
AtlasClear Holdings entered into an amendment to its debenture agreement with Sixth Borough Capital Fund, LP to extend the maturity date of a $500,000 loan from August 3, 2026, to February 3, 2027. The lender is an entity controlled by Robert D. Keyser, Jr., a member of the company's board of directors.
Centene Corporation is participating in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026. During the event, management will discuss business results and reaffirm its full-year 2026 guidance, including GAAP diluted EPS of greater than $3.11 and adjusted diluted EPS of greater than $4.80.
TPG Twin Brook Capital Income Fund Business Update
TPG Twin Brook Capital Income Fund (TCAP) provided a portfolio and market commentary update, reporting a $4.8 billion portfolio and a 4.9% year-to-date total return for Class I shares. The update highlighted defensive portfolio metrics including a 100% first-lien senior secured debt composition, a 0.2% non-accrual rate, and $563 million in commitments during the quarter.
Shuttle Pharmaceuticals issued approximately 3.7 million shares of common stock following the conversion of Series B-1 and B-2 Preferred Stock. Additionally, the company issued warrants to purchase 927,114 shares at $10.30 per share and pre-funded warrants for 16.9 million shares, following stockholder approval at a special meeting.
Vivmark Residential published an updated investor presentation and operating update in connection with its participation in the BofA Securities Global Real Estate Conference. The company, formed by the August 2026 merger of AvalonBay and Equity Residential, established a 2026 Same Store Residential revenue outlook of 2% at the midpoint and reported 95.7% physical occupancy.
Motorcar Parts of America held its Annual Meeting of Shareholders on September 10, 2026, where shareholders elected eight directors to the board and ratified Ernst & Young LLP as the independent auditor. Shareholders also approved the company's executive compensation on an advisory basis and authorized the Second Amendment to the 2022 Incentive Award Plan.
XCF Global, Inc. entered into a warrant purchase agreement with GL PART SPV II, LLC, raising $1.0 million in a private placement. The company issued an initial warrant to purchase up to 6,891,798 shares of Class A Common Stock at an exercise price of $2.50 per share. This transaction was a condition to the effectiveness of an amendment to the company's pending business combination agreement.
RF Industries held its Annual Meeting of Stockholders on September 10, 2026, where shareholders elected Gerald T. Garland as a Class II director for a three-year term. Stockholders also approved the compensation of named executive officers on an advisory basis and ratified CohnReznick LLP as the independent accounting firm for fiscal year 2026.
AEye, Inc. entered into an At Market Issuance Sales Agreement with A.G.P./Alliance Global Partners to establish an at-the-market (ATM) offering program for up to $50 million of common stock. Simultaneously, the company terminated its previous 2022 Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. No shares were reported sold at the time of this filing, and the company is under no obligation to sell any shares under the new agreement.